Brian McDonald »

Lineage Cell Therapeutics In shares owned by Brian McDonald

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Brian McDonald from 13F filings

Historical chart of Brian McDonald investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Brian McDonald consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Brian McDonald

Quarter filed Position value Share count Share price at filing
2024-03-31 $370k 250k 1.48
2023-09-30 $348 295 1.18

More positions owned by Brian McDonald

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Lilly Eli & Co Common (LLY)
Ishares Tr Tr-s&p 500 Index Common (IVV)
Nvidia Corp Common (NVDA)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Common (SPY)
Jpmorgan Chase & Co Common (JPM)
Home Depot Common (HD)
Alphabet Inc Cl A Common (GOOGL)
Facebook Common (META)
Ishares Tr Russell 1000 Growth Common (IWF)
Ishares Tr 1000 Etf Common (IWB)
Alphabet Inc Cl C Common (GOOG)
Visa Inc Cl A Common (V)

View all positions for Brian McDonald

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Group
Logos Global Management
Defender Capital
Geode Capital Management
Raffles Associates
State Street Corporation
Prescott General Partners
MAI Wealth Advisors
DAFNA Capital Management
Bank of America Corporation
Northern Trust
Bridgeway Capital Management
Jpmorgan Chase & Co

View all funds holding Lineage Cell Therapeutics In